Hillman Co. decreased its holdings in shares of RTI Surgical, Inc. (NASDAQ:RTIX) by 11.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,387,875 shares of the medical equipment provider’s stock after selling 294,999 shares during the period. RTI Surgical makes up about 2.8% of Hillman Co.’s holdings, making the stock its 11th biggest position. Hillman Co. owned approximately 3.93% of RTI Surgical worth $10,865,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in RTIX. Cigna Investments Inc. New purchased a new stake in shares of RTI Surgical during the 2nd quarter worth approximately $105,000. Prudential Financial Inc. purchased a new stake in shares of RTI Surgical during the 3rd quarter worth approximately $111,000. Citigroup Inc. boosted its stake in shares of RTI Surgical by 2,850.1% during the 2nd quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock worth $124,000 after acquiring an additional 20,435 shares in the last quarter. First Quadrant L P CA purchased a new stake in shares of RTI Surgical during the 2nd quarter worth approximately $137,000. Finally, American International Group Inc. boosted its stake in shares of RTI Surgical by 7.0% during the 1st quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock worth $141,000 after acquiring an additional 2,327 shares in the last quarter. Institutional investors own 68.37% of the company’s stock.
RTIX has been the topic of several research analyst reports. Zacks Investment Research lowered RTI Surgical from a “hold” rating to a “sell” rating in a research note on Thursday, October 5th. BidaskClub lowered RTI Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, August 8th.
RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.01. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The firm had revenue of $66.69 million for the quarter, compared to analyst estimates of $65.63 million. The business’s revenue was up .2% on a year-over-year basis. equities analysts forecast that RTI Surgical, Inc. will post 0.05 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://sportsperspectives.com/2017/11/24/rti-surgical-inc-rtix-holdings-cut-by-hillman-co.html.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Want to see what other hedge funds are holding RTIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTI Surgical, Inc. (NASDAQ:RTIX).
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.